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Supplementary Materials and Methods

Chemical synthesis and characterization
All reagents and solvents were purchased from commercially available sources and used without further purification. All reactions were carried out according to the indicated procedures and conditions. Flash Chromatography was performed on an Interchim PufiFlash 430 with cartridges filled with Silica gel 50 µm (PF-50SIHC). Reactions were monitored by LC/MS analysis and/or thin-layer chromatography (TLC) on silica-coated glass plates (EMD silica gel 60 F254) with the indicated eluent. The compounds were visualized by UV light (254 nm). LC/MS analysis was performed on an Agilent 1200 HPLC/UV (λ = 220 nm and/or 254 nm) system coupled with a mass spectroscopic (Applied Biosystems, MDS SCIEX, Q TRAP LC/MS/MS) detector. High-resolution mass spectrometry (HRMS) was performed on an Agilent 6530 QTOF Mass Spectrometer with 1290 Infinity Binary LC in the positive mode that utilizes electrospray ionization (ESI). Compounds for analysis were dissolved in 100% DMSO and separated on C18 cartridge (particle size 2.6 m, dimensions: 100 mm X 2.1 mm, 0.3 mL/min flow rate, 1 L injection volume) using acetonitrile/water mobile phase with 0.1% formic acid as a modifier. The gradient started at 0% acetonitrile, held for 1 min, and linearly increased to 97% acetonitrile over 9.25 min, with 1.75 min hold at 97% acetonitrile and subsequent reequilibration to the original conditions in a total of 17 min. All compounds reported were obtained in a purity of > 95% at 254 nm wavelength. Nuclear magnetic resonance (1H NMR) spectra were recorded on a Varian Mercury plus NMR spectrometer operating at 400.13 MHz frequencies for 1 H, using a 5 mm ASW PFG probe capable of detecting 1 H and 13 C nuclei. The proton chemical shifts (ppm) were referenced to the tetramethylsilane (TMS) internal standard (0 ppm) or DMSO-d6 methyl group (2.50 ppm). The splitting patterns are abbreviated as follows: s (singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), br (broad), and m (multiplet).
General Procedure A Methyl 6-(7-chloro-1H-indole-3-carbonyl)picolinate (PY186)
To a solution of 2,6-pyridinedicarboxylic acid monomethyl ester (1.0 mmol, 181 mg) in anhydrous dichloromethane (DCM) (5 mL), oxalyl chloride (5 mmol, 0.43 mL) was added slowly followed by a drop of dimethyl formamide (DMF). The reaction mixture was stirred at room temperature (rt) for 1 hr and then concentrated in vacuo to yield the methyl 6-chlorocarbonylpyridine-2-carboxylate as a yellow oil that was used without further purification. To a solution of 7-chloroindole (1.3 mmol, 197 mg) in 10 mL anhydrous DCM, Et2AlCl (1.3 mmol, 1.0 M in ethane) was slowly added at -78°C. The mixture was stirred for 15 min. The corresponding acid chloride, dissolved in DCM (2 mL), was added to the solution at -10°C. The reaction mixture was warmed to rt and stirred for 2 hr. The mixture was washed with water for 3 times. The mixture was concentrated to get a yellow residue. Purification was performed on an automated flash chromatography system with hexanes/EtOAc (3:1) to afford 130 mg (41%) of methyl 6-(7-chloro-1H-indole-3-carbonyl)picolinate as a brown solid. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 11.0 min; 
General Procedure B 6-(1H-indole-3-carbonyl)picolinonitrile PY108
To 6-cyanopyridine-2-carboxylic acid (350 mg, 2.4 mmol), thionyl chloride (2 mL) was added slowly followed by one drop of DMF. The reaction was heated to 40°C for 3 hr. After cooling to rt the solvent was removed in vacuo. The resulting 6-cyanopyridine-2-carbonyl chloride was dried overnight in vacuo and used without further purification. To a solution of indole (304 mg, 2.6 mmol) in anhydrous dichloroethane (DCE) (4 mL) at 0°C under nitrogen, 6-cyanopyridine-2-carbonyl chloride (2.4 mmol, in 3 mL DCE) was added by a syringe. Zirconiumtetrachloride (699 mg, 3.0 mmol) was added under a flow of nitrogen. The temperature was increased to 45°C and kept at this temperature until the reaction completion (24-30 hr). The mixture was quenched with water (15 mL) and extracted with EtOAc (3 X 50 mL). The combined organic layer was washed with water (10 mL), dried with anhydrous Na2SO4, and concentrated under vacuum. Purification was performed on a prep-HPLC (acetonitrile/water with 0.1% TFA as modifier; 30-97% acetonitrile over 25 min) to yield 100 mg (17%) of 6-(1H-indole-3-carbonyl)picolinonitrile as beige powder. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0. 2, 157.2, 139.5, 138.22, 138.17, 136.2, 131.4, 130.8, 126.62, 126.58, 123.32, 122.4, 121.5, 117.4, 113.3 
; HRMS (ESI/Q-TOF) m/z: [M + H]
+ Calcd for C15H10N3O 248.0818; Found 248.0820.
General Procedure C Methyl 6-(1H-indole-3-carbonyl)picolinate (PY10)
To a solution of indole (153 mg, 1.3 mmol) in 1.5 mL anhydrous DCM, methyl 6-chlorocarbonylpyridine-2-carboxylate dissolved in 2 mL DCM was added at 0°C. To the mixture was added and AlCl3 (200 mg, 1.5 mmol) at 0°C. The mixture was stirred for 15 min then slowly allowed warm to 30°C. The reaction was stirred for 4 hr at 30°C. TLC showed the disappearance of the starting material. The mixture was quenched with water (5 mL), extracted with EtOAc (10 mL X 3) washed with water (10 mL X 3), dried over Na2SO4, and concentrated. Purification was performed on an automated flash chromatography system with hexanes/EtOAc (3:1) to afford 120 mg (43%) of methyl 6-(1H-indole-3-carbonyl)picolinate as an off-white solid. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 9.9 min; 6, 164.8, 155.6, 146.1, 139.0, 138.2, 136.0, 127.0, 126.8, 125.9, 123.1, 122.2, 121.7, 113.6, 112.3, 52.8 
General Procedure D 6-(1H-indole-3-carbonyl)picolinic acid (PY145)
To a water solution of 3N NaOH (5 mL) was added methyl 6-(1H-indole-3-carbonyl)pyridine-2-carboxylate (100 mg, 0.38 mmol). The mixture was reacted by microwave reactor at 100°C for 10 min. TLC showed the disappearance of the starting material and formation of one major spot. The solution was cooled in an ice bath, and the pH was adjusted to 3-4 using 1 N HCl. The resulting suspension was chilled in a dry ice/acetone bath and thawed to 4°C overnight in a refrigerator. The precipitate was filtered, washed with cold water, and dried in a desiccator under vacuum to afford 85 mg (90%) of 6-(1H-indole-3-carbonyl)picolinic acid as a yellow solid. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 9. 
Ethyl 6-(1H-indole-3-carbonyl)picolinate (PY147)
To a solution of 6-(1H-indole-3-carbonyl)pyridine-2-carboxylic acid (0.3 mmol, 80 mg) in anhydrous DCM (5 mL) was slowly added (COCl)2 (1.5 mmol, 0.25 g) and a drop of DMF. The mixture was stirred at rt for 1 hr. The mixture was concentrated to produce the acid chloride as a light yellow liquid. The acid chloride was added into 10 mL EtOH and followed by addition of 4-dimethylaminopyridine (0.03 mmol, 4 mg). The mixture was stirred at rt overnight. TLC showed the disappearance of the starting material and the formation of one major spot. The mixture was concentrated and purification was performed on an automated flash chromatography system with hexanes/EtOAc 
Isopropyl 6-(1H-indole-3-carbonyl)picolinate (PY148)
The compound PY148 was synthesized as a pale solid (88%) 
Cyclohexyl 6-(1H-indole-3-carbonyl)picolinate (1h) (PY150)
The compound PY150 was synthesized as a pale solid (76%) 
6-(1H-indole-3-carbonyl)-N,N-dimethylpicolinamide (PY152)
The compound PY152 was synthesized a pale solid (45%) according to Procedure D. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 8.9 min; 
(2-Methyl-1H-indol-3-yl)(phenyl)methanone (BN143)
The compound BN143 was synthesized as a white solid (32%) according to Procedure A. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 10. 
Methyl 6-(2-methyl-1H-indole-3-carbonyl)picolinate (PY144)
The compound PY144 was synthesized as an off-white solid (32%) 
Methyl 6-(1-methyl-1H-indole-3-carbonyl)picolinate (PY162)
The compound PY162 was synthesized as a yellow solid (41%) 
Methyl 6-(4-chloro-1H-indole-3-carbonyl)picolinate (PY198)
The title compound PY198 was synthesized a brown solid (28%) 
Methyl 6-(5-methoxy-1H-indole-3-carbonyl)picolinate (PY257)
The compound PY257 was synthesized as a yellow solid (34%) according to Procedure A. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 9.8 min; 
Methyl 6-(1H-benzo[g]indole-3-carbonyl)picolinate (PY270)
The compound PY270 was synthesized as a yellow solid ( 
Methyl 2-(1H-indole-3-carbonyl)benzoate (BN197)
The compound BN197 was synthesized as a pink solid (36%) according to Procedure A. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 9.6 min; 
3-(1H-indole-3-carbonyl)phenyl acetate (BN203)
The compound BN203 was synthesized as a white solid (26%) according to Procedure A. HPLC analysis (C18 reverse phase, 17 mins, 0-97% H2O/ACN with 0.1% formic acid): tR = 9.9 min; 
